Buy Cray

The supercomputer company Cray (NASD: CRAY) got super trashed in May when it lowered near term earnings due to a component shortage. Those components, powerful new chips designed by Intel and Nvidia, are now available and should put Cray’s shipments back on track. Cray’s supercomputers are increasingly being used by commercial customers to analyze the tsunami of data landing on their servers. Earnings growth should resume to 20% with these new components in hand. Target: $40.

Stock Talk

Rich L

Richard

Good Evening Linda;

New subscriber, just joined yesterday, Monday.
Thank you for the Cray tip, and when you put out a target of $40, is that within the next 12 months?

Regards
Richard

Linda McDonough

Linda McDonough

Hi Richard,
Welcome aboard! Yes all of my targets are for a 12 month period. My hope when recommending a stock is that the target is raised over time as estimates increase. You will get an alert if a price target is changed.
Best,
Linda

Jon D.

Jon D.

Welcome aboard, I saw this headline on CRAY this AM, Cray started at overweight with $41 stock price target at Pacific Crest. Just made a decent but modest short term profit on DOOR. in just 2 days.
Get Okayed fer Options. Linda gave us a short time put option on a shoe distributor worked out well, and quickly too.

Garfield

Garfield

August 17th is a date seen on the internet recently, is the stock referenced Lattice Semiconductors?

Linda McDonough

Linda McDonough

I am not sure what the August 17 date you are referring to- can you give me a bit more information about your question?
Linda

Garfield

Garfield

Information today is ” New England Journal of Medicine” reported the medicine is a universal antidote and will be in all hospitals following FDA release 8/17. We wait and see?

Rich L

Rich L

Good Morning Jon;

Changed my handle from Richard to Rich L, just in case another Richard showed up.

Thank you for the welcome greeting and the update on Cray.
I have not pulled the trigger on Cray yet, as I am watching the way it behaves and trades first.
It had gone down maybe a $1 since Linda recommended it, but is recovering.
I do like the story on Cray, and might eventually take a position.

Regards
Richard

Thomas Sublette

Thomas Sublette

Yes. Tom Sublette Just signed up for the Growth Stock Strategist. So here on Saturday getting an
edge for next week.

Garfield

Garfield

Do you have any information on the company that may release its name for the 8/17 FDA target date?

rjd

rjd

What happen to Cray, what is the outlook over the next 60 days?

Add New Comments

You must be logged in to post to Stock Talk OR create an account